Dishman Carbogen Amcis Ltd
As of 20 Nov 2026, Dishman Carbogen Amcis is in Stage 4, the downtrend phase, now in week 14 (since 11 Aug 2026). It closed at ₹116, 56.4% below its 52-week high and below its 200-day average, which is falling. In Health Care, 34.7% of stocks are in Stage 2.
Dishman Carbogen Amcis Limited provides contract research and manufacturing services for the pharmaceutical and healthcare industries worldwide. More about the company
Pro read
ProDCAL is in a decline, 34% below its 200-day average. Declining stocks have lagged the market more than any other group; we wait for a base before looking again.
Its relative strength is 5 of 99, below the middle among NSE stocks over the past year. Labs & Life Sciences Services ranks 70 of 106 industries by the strength of its stocks.
Is DCAL early, or has it already run? Pro answers that for every NSE stock, after every close.
DCAL among Labs & Life Sciences Services6th of 6 by relative strength
All 6 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | DIVISLAB | Stage 2 · wk 26 | 93 | +21.7% |
| 2 | AARTIPHARM | Stage 2 · wk 13 | 84 | +17.5% |
| 3 | VIMTALABS | Stage 3 · wk 5 | 30 | −4.3% |
| 4 | SYNGENE | Stage 1 · wk 1 | 23 | +20.0% |
| 5 | BROOKS | Stage 1 · wk 3 | 16 | +10.6% |
| 6 | DCAL | Stage 4 · wk 14 | 5 | −18.7% |
Mutual fund holdings
Held by 4 mutual funds in portfolios to October 2026: 0 active funds and 4 index funds and ETFs.
In October, no active fund changed its holding.
All 4 funds and what each did in October
Mutual funds holding DCAL: the ten largest and the month’s moves →
Dishman Carbogen Amcis: quick answers
What stage is Dishman Carbogen Amcis in?
As of 20 Nov 2026, Dishman Carbogen Amcis (DCAL) is in Stage 4, the downtrend phase. It entered Stage 4 on 11 Aug 2026 and is in week 14. What the four stages mean
Is Dishman Carbogen Amcis in an uptrend?
No. Dishman Carbogen Amcis is in a Stage 4 downtrend. It trades 33.8% below its 200-day average, which is falling.
How far is Dishman Carbogen Amcis from its 52-week high?
Dishman Carbogen Amcis closed at ₹116 on 20 Nov 2026, 56.4% below its 52-week high of ₹265. Its 52-week low is ₹116.
How has Dishman Carbogen Amcis performed over the past year?
As of 20 Nov 2026, Dishman Carbogen Amcis is down 53.0% over the past year and down 53.3% so far in 2026.
Which sector and industry is Dishman Carbogen Amcis in?
Dishman Carbogen Amcis is in the Labs & Life Sciences Services industry, part of the Health Care sector. 61 stocks in Health Care are in Stage 2, 34.7% of the sector. See the Stage 2 stocks in Health Care
About this companyHealth Care· Labs & Life Sciences Services
Dishman Carbogen Amcis Limited provides contract research and manufacturing services for the pharmaceutical and healthcare industries worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It offers cholesterol and vitamin D analogs; generic active pharmaceutical ingredients for diagnostics, ophthalmic treatments, laxatives, organophosphate antidotes; ammonium, phosphonium; quats, phosphoranes, and wittig reagents; cholesterol and lanolin-related products; sterile injectables; and softgel formulations, as well as hand and body wash, sanitisers, and antiseptics. The company was founded in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP.
Visit company website →All analytics based on EOD data. Data as of 2026-11-20. Past data patterns are not indicative of future results. This page is a data analytics tool only.